267 research outputs found
Influence of branch content on the microstructure of blends of linear and octene-branched polyethylene: a MD simulation study
MOLECULAR DYNAMICS SIMULATION OF THE INFLUENCE OF BRANCH CONTENT ON THE MISCIBILITY OF HDPE IN METALLOCENE OCTENE-LLDPES
Miscibility of linear high-density polyethylene (HDPE) and series of metallocene octene-based linear low-density polyethylene (m-LLDPE) with different branch contents were studied by molecular dynamic (MD) simulation. m-LLDPEs were modeled as ethylene-octene copolymers with octene uniformly distributed on the PE chain. In the MD simulation, chains were modeled using united atom approach in the NVT ensemble. The branch content (BC) was varied in the range 10–80 branches/1000C. The miscibility of HDPE/m-LLDPE blends was inferred from the steady-state conformation of the blend. Miscibility was found to be a function of BC. Miscibility was observed in blends of up to 40 branches/1000 C; however, blends were found to be immiscible in higher ranges (50-80 BC). MD Simulation results agree with previous experimental reports of Hill’s group
MOLECULAR DYNAMICS SIMULATION OF THE INFLUENCE OF BRANCH CONTENT ON THE MISCIBILITY OF HDPE IN METALLOCENE OCTENE-LLDPES
Miscibility of linear high-density polyethylene (HDPE) and series of metallocene octene-based linear low-density polyethylene (m-LLDPE) with different branch contents were studied by molecular dynamic (MD) simulation. m-LLDPEs were modeled as ethylene-octene copolymers with octene uniformly distributed on the PE chain. In the MD simulation, chains were modeled using united atom approach in the NVT ensemble. The branch content (BC) was varied in the range 10–80 branches/1000C. The miscibility of HDPE/m-LLDPE blends was inferred from the steady-state conformation of the blend. Miscibility was found to be a function of BC. Miscibility was observed in blends of up to 40 branches/1000 C; however, blends were found to be immiscible in higher ranges (50-80 BC). MD Simulation results agree with previous experimental reports of Hill’s group
Influence of branch content on the microstructure of blends of linear and octene-branched polyethylene: a MD simulation study
Nutritional and hematological status of Sudanese women of childbearing age with steady-state sickle cell anemia
We sought to investigate the nutritional and hematological status of Sudanese women of childbearing age with sickle cell anemia (SCA). Anthropometry and hematology were used to assess nutritional status and health and disease conditions, respectively. Women with steady-state (HbSS, n = 39; age = 19.0±2.7) and without (HbAA, n = 36; age, 19.8±2.7) SCA were recruited during a routine visit to the Hematology Clinic, Ibn-Auf Teaching Hospital, Khartoum, Sudan. The two groups of women lived in similar environmental conditions and ate similar diets three times a day. However, despite taking regular meals, the women with sickle anemia were thinner and lighter ( 0.050). The low anthropometric (height, weight, and body mass index) and abnormal hematological values in the women with SCA in steady-state reflect sustained nutritional insults inflected by the disease and poverty. Tailored nutritional counseling/advice must be an integral part of managing patients with SCA. Such advice is particularly vital for women of childbearing age because of the adverse effects of prepregnancy nutritional deficiency on outcomes
Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical Trial
Importance: Adoption of guideline-directed medical therapy for patients with heart failure is variable. Interventions to improve guideline-directed medical therapy have failed to consistently achieve target metrics, and limited data exist to inform efforts to improve heart failure quality of care.
Objective: To evaluate the effect of a hospital and postdischarge quality improvement intervention compared with usual care on heart failure outcomes and care.
Design, Setting, and Participants: This cluster randomized clinical trial was conducted at 161 US hospitals and included 5647 patients (2675 intervention vs 2972 usual care) followed up after a hospital discharge for acute heart failure with reduced ejection fraction (HFrEF). The trial was performed from 2017 to 2020, and the date of final follow-up was August 31, 2020.
Interventions: Hospitals (n = 82) randomized to a hospital and postdischarge quality improvement intervention received regular education of clinicians by a trained group of heart failure and quality improvement experts and audit and feedback on heart failure process measures (eg, use of guideline-directed medical therapy for HFrEF) and outcomes. Hospitals (n = 79) randomized to usual care received access to a generalized heart failure education website.
Main Outcomes and Measures: The coprimary outcomes were a composite of first heart failure rehospitalization or all-cause mortality and change in an opportunity-based composite score for heart failure quality (percentage of recommendations followed).
Results: Among 5647 patients (mean age, 63 years; 33% women; 38% Black; 87% chronic heart failure; 49% recent heart failure hospitalization), vital status was known for 5636 (99.8%). Heart failure rehospitalization or all-cause mortality occurred in 38.6% in the intervention group vs 39.2% in usual care (adjusted hazard ratio, 0.92 [95% CI, 0.81 to 1.05). The baseline quality-of-care score was 42.1% vs 45.5%, respectively, and the change from baseline to follow-up was 2.3% vs -1.0% (difference, 3.3% [95% CI, -0.8% to 7.3%]), with no significant difference between the 2 groups in the odds of achieving a higher composite quality score at last follow-up (adjusted odds ratio, 1.06 [95% CI, 0.93 to 1.21]).
Conclusions and Relevance: Among patients with HFrEF in hospitals randomized to a hospital and postdischarge quality improvement intervention vs usual care, there was no significant difference in time to first heart failure rehospitalization or death, or in change in a composite heart failure quality-of-care score.
Trial Registration: ClinicalTrials.gov Identifier: NCT03035474
Measurement of the Forward-Backward Asymmetry in the B -> K(*) mu+ mu- Decay and First Observation of the Bs -> phi mu+ mu- Decay
We reconstruct the rare decays , , and in a data sample
corresponding to collected in collisions at
by the CDF II detector at the Fermilab Tevatron
Collider. Using and decays we report the branching ratios. In addition, we report
the measurement of the differential branching ratio and the muon
forward-backward asymmetry in the and decay modes, and the
longitudinal polarization in the decay mode with respect to the squared
dimuon mass. These are consistent with the theoretical prediction from the
standard model, and most recent determinations from other experiments and of
comparable accuracy. We also report the first observation of the {\mathcal{B}}(B^0_s \to
\phi\mu^+\mu^-) = [1.44 \pm 0.33 \pm 0.46] \times 10^{-6}27 \pm 6B^0_s$ decay observed.Comment: 7 pages, 2 figures, 3 tables. Submitted to Phys. Rev. Let
Measurements of the properties of Lambda_c(2595), Lambda_c(2625), Sigma_c(2455), and Sigma_c(2520) baryons
We report measurements of the resonance properties of Lambda_c(2595)+ and
Lambda_c(2625)+ baryons in their decays to Lambda_c+ pi+ pi- as well as
Sigma_c(2455)++,0 and Sigma_c(2520)++,0 baryons in their decays to Lambda_c+
pi+/- final states. These measurements are performed using data corresponding
to 5.2/fb of integrated luminosity from ppbar collisions at sqrt(s) = 1.96 TeV,
collected with the CDF II detector at the Fermilab Tevatron. Exploiting the
largest available charmed baryon sample, we measure masses and decay widths
with uncertainties comparable to the world averages for Sigma_c states, and
significantly smaller uncertainties than the world averages for excited
Lambda_c+ states.Comment: added one reference and one table, changed order of figures, 17
pages, 15 figure
- …